Featured Articles

We are committed to partnering with academia, organizations and other companies to accelerate vaccine development and ultimately increase access globally. Our collaborations with worldwide vaccine developers and researchers include:

• Leveraging previous efforts at an adenovirus-based vaccine platform for rapid development of a Covid-19 vaccine platform (read more)
• Building on previous collaborations with the Baylor College of Medicine to optimize production of two Covid-19 vaccine candidates (read more)
• Joining the DiViNe Consortium in Europe to address low yields and high costs of vaccine purification (read our white paper)
• Developing optimized purification processes with the International Vaccine Institute (read more)
• Receiving a grant from the Bill & Melinda Gates Foundation as part of a consortium pursuing a new manufacturing platform that would radically increase vaccine availability and affordability in developing countries (read more)

Contact us today to discuss your needs with a technical representative, and discover new solutions for better, faster, safer vaccine development. Or listen to our GEN Podcast, “Vaccinating the World One Collaboration at a Time.”